A recent study investigating the influence of obesity on IDD has identified CXCL16 as a potential diagnostic biomarker for both obesity and IDD, highlighting its role in regulating fatty acid metabolism and facilitating IDD progression (12). This evidence concerns the gene CXCL16 and obesity due to melanocortin 4 receptor deficiency.